Dr. Benjamin Neel has strong experience in oncology, cancer cell signaling pathways, the role of pathway mutations, and their effects on disease development and cancer genomics. He serves as a Professor of Medicine at the NYU School of Medicine and Director of the Perlmutter Cancer Center at NYU Langone Health. Prior to joining NYU Langone, he served as Director of the Princess Margaret Cancer Center at University Health Network, which includes the Ontario Cancer Institute and Campbell Family Cancer Research Institute. Dr. Neel was also William B. Castle Professor of Medicine at Harvard Medical School. He is a Founder of Northern Biologics Inc. and previously served as a member of the Board of Directors. He is also a Founder of Navire Pharma, Inc. and the Chair of its Scientific Advisory Board. Dr. Neel previously served as a Director of the American Association of Cancer Research and currently is on the Board of Directors of the American Association of Cancer Institutes. He was also a member of the Medical Advisory Board of the Gairdner Foundation.